Elena M. Sorokina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Elena M. Sorokina has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Melike Lakadamyali
University of Pennsylvania
5 shared publications - Attila Oravecz
Institut de Génétique et de Biologie Moléculaire et Cellulaire, 67404 Illkirch, France
2 shared publications - Carlos Ernesto Castro
The Ohio State University
2 shared publications - Gaurav Arya
Duke University
2 shared publications - Golbarg Mohammadi Roozbahani
Department of Chemistry, Illinois Institute of Technology, Chicago, USA
2 shared publications - Laszlo Tora
Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch, France
2 shared publications
Latest Publications
- Open Access
- 1 November 2024
- Published by Rockefeller University Press in Journal of Cell Biology
- Vol. 224 (1)
Heterogeneity of late endosome/lysosomes shown by multiplexed DNA-PAINT imaging
Late endosomes/lysosomes (LELs) are crucial for numerous physiological processes and their dysfunction is linked to many diseases. Proteomic analyses have identified hundreds of LEL proteins; however, whether these proteins are uniformly present on each LEL, or if there are cell-type-dependent LEL subpopulations with unique protein compositions is unclear. We employed quantitative, multiplexed DNA-PAINT super-resolution imaging to examine the distribution of seven key LEL proteins (LAMP1, LAMP2, CD63, Cathepsin D, TMEM192, NPC1, and LAMTOR4). While LAMP1, LAMP2, and Cathepsin D were abundant across LELs, marking a common population, most analyzed proteins were associated with specific LEL subpopulations. Our multiplexed imaging approach identified up to eight different LEL subpopulations based on their unique membrane protein composition. Additionally, our analysis of the spatial relationships between these subpopulations and mitochondria revealed a cell-type-specific tendency for NPC1-positive LELs to be closely positioned to mitochondria. Our approach will be broadly applicable to determining organelle heterogeneity with single organelle resolution in many biological contexts.
- 1 November 2024
- Published by Rockefeller University Press in Journal of Cell Biology
- Vol. 224 (1)
Open AccessHeterogeneity of late endosome/lysosomes shown by multiplexed DNA-PAINT imaging
Late endosomes/lysosomes (LELs) are crucial for numerous physiological processes and their dysfunction is linked to many diseases. Proteomic analyses have identified hundreds of LEL proteins; however, whether these proteins are uniformly present on each LEL, or if there are cell-type-dependent LEL subpopulations with unique protein compositions is unclear. We employed quantitative, multiplexed DNA-PAINT super-resolution imaging to examine the distribution of seven key LEL proteins (LAMP1, LAMP2, CD63, Cathepsin D, TMEM192, NPC1, and LAMTOR4). While LAMP1, LAMP2, and Cathepsin D were abundant across LELs, marking a common population, most analyzed proteins were associated with specific LEL subpopulations. Our multiplexed imaging approach identified up to eight different LEL subpopulations based on their unique membrane protein composition. Additionally, our analysis of the spatial relationships between these subpopulations and mitochondria revealed a cell-type-specific tendency for NPC1-positive LELs to be closely positioned to mitochondria. Our approach will be broadly applicable to determining organelle heterogeneity with single organelle resolution in many biological contexts.
- Open Access
- 5 July 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (27) , eadn9423
Piggybacking functionalized DNA nanostructures into live-cell nuclei
DNA origami nanostructures (DOs) are promising tools for applications including drug delivery, biosensing, detecting biomolecules, and probing chromatin substructures. Targeting these nanodevices to mammalian cell nuclei could provide impactful approaches for probing, visualizing, and controlling biomolecular processes within live cells. We present an approach to deliver DOs into live-cell nuclei. We show that these DOs do not undergo detectable structural degradation in cell culture media or cell extracts for 24 hours. To deliver DOs into the nuclei of human U2OS cells, we conjugated 30-nanometer DO nanorods with an antibody raised against a nuclear factor, specifically the largest subunit of RNA polymerase II (Pol II). We find that DOs remain structurally intact in cells for 24 hours, including inside the nucleus. We demonstrate that electroporated anti–Pol II antibody–conjugated DOs are piggybacked into nuclei and exhibit subdiffusive motion inside the nucleus. Our results establish interfacing DOs with a nuclear factor as an effective method to deliver nanodevices into live-cell nuclei.
- 5 July 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (27) , eadn9423
Open AccessPiggybacking functionalized DNA nanostructures into live-cell nuclei
DNA origami nanostructures (DOs) are promising tools for applications including drug delivery, biosensing, detecting biomolecules, and probing chromatin substructures. Targeting these nanodevices to mammalian cell nuclei could provide impactful approaches for probing, visualizing, and controlling biomolecular processes within live cells. We present an approach to deliver DOs into live-cell nuclei. We show that these DOs do not undergo detectable structural degradation in cell culture media or cell extracts for 24 hours. To deliver DOs into the nuclei of human U2OS cells, we conjugated 30-nanometer DO nanorods with an antibody raised against a nuclear factor, specifically the largest subunit of RNA polymerase II (Pol II). We find that DOs remain structurally intact in cells for 24 hours, including inside the nucleus. We demonstrate that electroporated anti–Pol II antibody–conjugated DOs are piggybacked into nuclei and exhibit subdiffusive motion inside the nucleus. Our results establish interfacing DOs with a nuclear factor as an effective method to deliver nanodevices into live-cell nuclei.
- Open Access
Piggybacking functionalized DNA nanostructures into live cell nuclei
DNA origami (DO) are promising tools for in vitro or in vivo applications including drug delivery; biosensing, detecting biomolecules; and probing chromatin sub-structures. Targeting these nanodevices to mammalian cell nuclei could provide impactful approaches for probing visualizing and controlling important biological processes in live cells. Here we present an approach to deliver DO strucures into live cell nuclei. We show that labelled DOs do not undergo detectable structural degradation in cell culture media or human cell extracts for 24 hr. To deliver DO platforms into the nuclei of human U2OS cells, we conjugated 30 nm long DO nanorods with an antibody raised against the largest subunit of RNA Polymerase II (Pol II), a key enzyme involved in gene transcription. We find that DOs remain structurally intact in cells for 24hr, including within the nucleus. Using fluorescence microscopy we demonstrate that the electroporated anti-Pol II antibody conjugated DOs are efficiently piggybacked into nuclei and exihibit sub-diffusive motion inside the nucleus. Our results reveal that functionalizing DOs with an antibody raised against a nuclear factor is a highly effective method for the delivery of nanodevices into live cell nuclei.
Open AccessPiggybacking functionalized DNA nanostructures into live cell nuclei
DNA origami (DO) are promising tools for in vitro or in vivo applications including drug delivery; biosensing, detecting biomolecules; and probing chromatin sub-structures. Targeting these nanodevices to mammalian cell nuclei could provide impactful approaches for probing visualizing and controlling important biological processes in live cells. Here we present an approach to deliver DO strucures into live cell nuclei. We show that labelled DOs do not undergo detectable structural degradation in cell culture media or human cell extracts for 24 hr. To deliver DO platforms into the nuclei of human U2OS cells, we conjugated 30 nm long DO nanorods with an antibody raised against the largest subunit of RNA Polymerase II (Pol II), a key enzyme involved in gene transcription. We find that DOs remain structurally intact in cells for 24hr, including within the nucleus. Using fluorescence microscopy we demonstrate that the electroporated anti-Pol II antibody conjugated DOs are efficiently piggybacked into nuclei and exihibit sub-diffusive motion inside the nucleus. Our results reveal that functionalizing DOs with an antibody raised against a nuclear factor is a highly effective method for the delivery of nanodevices into live cell nuclei.
- 5 May 2021
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 118 (19)
Tau forms oligomeric complexes on microtubules that are distinct from tau aggregates
Significance: Tau is a neuronal protein whose aggregation is a hallmark of several neurodegenerative diseases collectively known as tauopathies. Due to a lack of suitable tools, discriminating small, pathological tau aggregates from physiological tau within cells has been difficult. Using super-resolution microscopy, we show that tau forms dimers and trimers on microtubules ex vivo. These dimeric/trimeric tau complexes are distinct from tau aggregates formed in a cell model of frontotemporal dementia with parkinsonism linked to chromosome 17. Machine learning–based classification further shows that hyperphosphorylation of specific tau residues is associated with the formation of distinct tau aggregates. Our approach opens the door to detecting pathological tau oligomers in disease and to screening for drugs that can disrupt these pathological oligomers.
- 5 May 2021
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 118 (19)
Tau forms oligomeric complexes on microtubules that are distinct from tau aggregates
Significance: Tau is a neuronal protein whose aggregation is a hallmark of several neurodegenerative diseases collectively known as tauopathies. Due to a lack of suitable tools, discriminating small, pathological tau aggregates from physiological tau within cells has been difficult. Using super-resolution microscopy, we show that tau forms dimers and trimers on microtubules ex vivo. These dimeric/trimeric tau complexes are distinct from tau aggregates formed in a cell model of frontotemporal dementia with parkinsonism linked to chromosome 17. Machine learning–based classification further shows that hyperphosphorylation of specific tau residues is associated with the formation of distinct tau aggregates. Our approach opens the door to detecting pathological tau oligomers in disease and to screening for drugs that can disrupt these pathological oligomers.
- Open Access
- 19 December 2018
- Published by Rockefeller University Press in Journal of Cell Biology
- Vol. 218 (2) , 632-643
Detyrosinated microtubules spatially constrain lysosomes facilitating lysosome–autophagosome fusion
Microtubule post-translational modifications impart functional diversity to microtubules by affecting their dynamics, organization, and interaction with proteins. Using super-resolution microscopy, we show that only a small subpopulation of microtubules are detyrosinated in epithelial cells, while acetylated and tyrosinated microtubules comprise the majority of all microtubules. Surprisingly, lysosomes are enriched by approximately threefold on detyrosinated microtubules. Further, their motility on detyrosinated microtubules is impaired, showing shorter runs and more frequent and longer pauses. Lysosome enrichment is mediated through a kinesin-1–dependent mechanism, since knocking down this motor abolishes enrichment. Finally, correlative live-cell and super-resolution microscopy showed that lysosomes interact with autophagosomes on detyrosinated microtubules. Removal of detyrosinated microtubules or knockdown of kinesin-1 leads to a decrease in the percentage of autolysosomes, a fusion intermediate of autophagosomes and lysosomes. Taken together, our data reveal a new role of detyrosinated microtubules as hubs that spatially concentrate lysosomes on a small subset of microtubules and facilitate their interaction and fusion with autophagosomes to initiate autophagy.
- 19 December 2018
- Published by Rockefeller University Press in Journal of Cell Biology
- Vol. 218 (2) , 632-643
Open AccessDetyrosinated microtubules spatially constrain lysosomes facilitating lysosome–autophagosome fusion
Microtubule post-translational modifications impart functional diversity to microtubules by affecting their dynamics, organization, and interaction with proteins. Using super-resolution microscopy, we show that only a small subpopulation of microtubules are detyrosinated in epithelial cells, while acetylated and tyrosinated microtubules comprise the majority of all microtubules. Surprisingly, lysosomes are enriched by approximately threefold on detyrosinated microtubules. Further, their motility on detyrosinated microtubules is impaired, showing shorter runs and more frequent and longer pauses. Lysosome enrichment is mediated through a kinesin-1–dependent mechanism, since knocking down this motor abolishes enrichment. Finally, correlative live-cell and super-resolution microscopy showed that lysosomes interact with autophagosomes on detyrosinated microtubules. Removal of detyrosinated microtubules or knockdown of kinesin-1 leads to a decrease in the percentage of autolysosomes, a fusion intermediate of autophagosomes and lysosomes. Taken together, our data reveal a new role of detyrosinated microtubules as hubs that spatially concentrate lysosomes on a small subset of microtubules and facilitate their interaction and fusion with autophagosomes to initiate autophagy.
- Open Access
- 1 April 2016
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
- Vol. 1864 (4) , 419-425
Binding sites for interaction of peroxiredoxin 6 with surfactant protein A
- 1 April 2016
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
- Vol. 1864 (4) , 419-425
Open AccessBinding sites for interaction of peroxiredoxin 6 with surfactant protein A